Mucopolysaccharidosis type I (MPS I): Disease awareness for early diagnosis

This HowItreat.MD activity was developed under the direction and sponsorship of Sanofi Genzyme. All images (except patient profile images) are owned by Sanofi Genzyme unless otherwise indicated. Please note any images included are used for representative purposes only and are not actual patients.

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.

 For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location. For instance, in Europe, full prescribing information is available from the European Medicines Agency (ema.europa.eu), and in the United States, from the US Food and Drug Administration (fda.gov).

 All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for a global audience of healthcare professionals. To proceed, please confirm that you are a healthcare professional.

Modules

• A teenager with newly diagnosed dual heart valve disease

• A 4-year-old girl with joint contractures and corneal clouding